5 Longs Of The Shorts: Deckers Outdoor Corp (DECK), Tesla Motors Inc (TSLA), Skullcandy Inc (SKUL)

Page 1 of 2

Investing in highly shorted stocks is always risky business, especially when these stocks have some of the highest short interest around. The five stocks below all have short interest in excess of 40%, but could be worth taking a look at on the long side. One slight problem with highly shorted stocks is that they are sometimes shorted for a reason. Question is; is the short interest overdone and is their reason to go long any, or all, of these stocks? The five stocks below are highly shorted, but could be worth a closer look for investors looking to add a little speculation to their portfolio.

Tesla Motors Inc (NASDAQ:TSLA)All the high-short stocks appear to be cheap from a valuation standpoint, but could this be due to an overpressured stock price, let’s take a closer look. Over the past twelve months, Skullcandy Inc (NASDAQ:SKUL), Vera Bradley, Inc. (NASDAQ:VRA and Deckers Outdoor Corp (NASDAQ:DECK) are all down over 20%, but Coinstar, Inc. (NASDAQ:CSTR) and Tesla Motors Inc (NASDAQ:TSLA) are up.


Stock Performance
Skullcandy Vera Bradley (NASDAQ:VRA) Deckers Coinstar Tesla
Trailing Twelve Months -43% -24% -51% 16% 66%
Five Years -64% -6% 0% 100% 97%

Skullcandy Inc (NASDAQ:SKUL) has 53%short interest and manufactures headphone and other audio products. The stock is down nearly 40% over the last twelve months and hedge fund interest has been relatively weak for the headphone company. The squeeze, short squeeze that is, has been coming for some time, but Skullcandy is still waiting. The stock is down over 50% over the last six months alone despite meeting or beating earnings in each of the last four quarters. This company is like a number of others below, still growing and still profitable, but getting little attention from long investors, and a lot of attention from shorts. The slowdown may well be attributed to the over-focus of its business model, which relies heavily on consumer discretionary spending. However, with declining unemployment and an improving economy, the company should be able to achieve its projected (by Wall Street analysts) 18% five-year annual earnings growth.

With a market cap of only $180 million, Skullcandy could also be the target of a buyout. Bloomberg even reported that the sharp decline in the stock in the past eighteen months has made the company an attractive takeover target. Skullcandy’s long-term initiatives relate to its plans to expand beyond the U.S., which has been its primary market. Skullcandy is trading at a 7 times earnings, where the industry is near 12 times. Other key metrics that bode well for the valuation includes its S&P relative value. Compared to the S&P 500 price to earnings ratio, Skullcandy has traded at 98% of the S&P 500 P/E over the last five years (on average), but now only trades at 47%.

Vera Bradley, Inc. (NASDAQ:VRA), with around 53% short interest, is a designer and producer of accessories for women, including handbags and leisure items. Vera also has billionaire Steven Cohen as one of its top investors (check out all the hedge funds loving Vera). Vera recently upped its fourth quarter 2012 revenue and earnings guidance, as well as gross margin expectations, now expected to expand 140 basis points for the quarter, year over year. Much of company’s previous weakness has been related to inventory buildup; a problem that management has identified and foresees no issues in being able to move this year. Despite consumer spending weakness in the past, Vera plans to capitalize on an improving economy and even added 54 locations in Dillard stores during the third quarter. Other expansion efforts includes its early-stage entry into Japan. Vera, much like Skullcandy, looks cheap on a relative S&P 500 P/E basis. The company has traded around 150% of the S&P 500 P/E over the last five years, but currently trades at 105%. Vera also boosts one of the top returns on equity at 44%, compared to 16% industry average.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!